EUCTR2012-005246-38-NO
Active, not recruiting
Not Applicable
The effects of methylphenidate on brain processes for decision making in adult attention deficit hyperactivity disorder
niversity of Oslo0 sitesFebruary 7, 2013
ConditionsAttention deficit hyperactivty disorderMedDRA version: 15.1Level: PTClassification code 10003736Term: Attention deficit/hyperactivity disorderSystem Organ Class: 10037175 - Psychiatric disordersTherapeutic area: Psychiatry and Psychology [F] - Behaviours [F01]
DrugsRitalin
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Attention deficit hyperactivty disorder
- Sponsor
- niversity of Oslo
- Status
- Active, not recruiting
- Last Updated
- 12 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •The prospective patient participants at screening prior to receiving study agent must meet all of the following conditions:
- •Comply with DSM\-IV criteria for ADHD.
- •On stable treatment with MPH.
- •Must be between the age of 18 and 40\.
- •Signed informed consent and expected cooperation of the patients for the intervention and the test dates must be obtained and documented according to ICH GCP, and national/local regulations.
- •One subgroup of the study will be drug\-naïve ADHD patients, before they start medical treatment (newly diagnosed and awaiting approval from cardiologist to start drug treatment). After medication start, these patients will be recruited to continue the experiment as the other participants.
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1\.2 Adults (18\-64 years) yes
- •F.1\.2\.1 Number of subjects for this age range 150
Exclusion Criteria
- •Treatment with the following groups of pharmacological agents will be considered as exclusion criteria for participation:
- •Antidepressants (MOA\-inhibitors, Tricyclic antidepressants, SSRIs)
- •Antipsychotics (both first and second generation)
- •Anxiolytics/hypnotics (benzodiazepines, barbiturates)
- •History of alcohol or drug abuse.
- •History of moderate to severe head injury.
- •Major psychiatric comorbidity (i.e. psychosis, active suicidal ideation or acute exacerbation of other psychiatric condition in need of immediate treatment).
- •History of severe memory loss
- •Under treatment for metabolic disorders
- •Severe primary sensory loss
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
Effect of methylphenidate on neural mechanisms underlying attention deficit after closed head injuryAttention deficit after closed head injuryMental and Behavioural DisordersIntracranial injuryISRCTN27103516Department of Health (UK)20
Active, not recruiting
Not Applicable
Effect of treatment with methylphenidate on mental fatigue (brain fatigue”) and pain on persons who have suffered a traumatic brain injury or whip lash injury – a pilot study.Mental fatigue after traumatic brain injury or whip-lash injuryEUCTR2011-000925-60-SEKungälv Hospital30
Suspended
Not Applicable
Methylphenidate physiological and physical performance effectsPACTR202011697726048ational Lottery Distribution Trust Fund70
Terminated
Phase 4
Efficacy of methylphenidate and Attention Process Training in traumatic brain injury rehabilitatioTraumatic Brain Injury (TBI)Injuries and Accidents - Other injuries and accidentsPhysical Medicine / Rehabilitation - Other physical medicine / rehabilitationNeurological - Other neurological disordersACTRN12612000484842Monash University160
Not yet recruiting
Not Applicable
Effects of Methylphenidate and Sulpiride on Brain and Cognition: An exploratory PET, Pharmaco-fMRI StudyDopamine, cognition, working memory, striatumNL-OMON28994Donders Institute for Brain, Cognition, and Behaviour, Centre for Cognition, Radboud University Nijmegen100